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Abstract
Background—Youth-onset type 2 diabetes (T2D) is a disease that is newly emerging and 
behavioral strategies for its prevention are limited. Interventions that target the lifestyle behaviors 
of adolescents, to improve poor dietary quality and reduce excessive sedentariness, promise to 
reduce the risk of developing T2D. Health coaching is effective for promoting healthy behaviors in 
patients who have chronic disease, but few experimental studies are in adolescents. This 
randomized controlled trial, in adolescents with prediabetes, will determine the effectiveness of a 
health coaching intervention to facilitate adoption of healthy diet and activity behaviors that delay 
or prevent development of T2D.
Methods/design—The Dietary Intervention for Glucose Tolerance In Teens (DIG IT) trial will 
involve an evaluation of a health coaching intervention in adolescents with prediabetes. Eligible 
participants will be randomized to receive 6 months of health coaching or a single dietary 
consultation that is standard-of-care. The primary outcome will be 2-hour oral glucose tolerance 
test concentration. Secondary outcomes will include measures of glycemia and insulin action as 
well as dietary, physical activity and sedentary behaviors measured using an electronic food 
record, and by inclinometer. Data will be collected before and after the intervention (at 6 months) 
and at 12 months (to assess sustainability).
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Discussion—This trial will determine whether a health coaching intervention, a personalized 
and low-cost approach to modify dietary and activity behaviors, is effective and sustainable for 
prevention of youth-onset T2D, relative to standard-of-care. Health coaching has the potential to 
be widely implemented in clinical or community settings.
1. Background
Youth-onset type 2 diabetes (T2D) is an emerging condition linked with pediatric obesity. 
The prevalence has increased approximately 30% in the United States (U.S.) between 2001 
and 2009 [1]. Prediabetes is the precursor of T2D and recent studies have estimated its 
prevalence in adolescents to be 16.1% [2]. Once an adolescent has developed T2D, the 
prognosis is worrisome because of poor glycemic control, even with the use of conventional 
medications, leading to early progression of chronic complications and lower life expectancy 
[3–5]. The problem of youth-onset T2D is especially challenging since obesity is difficult to 
treat in children [6].
The Diabetes Prevention Program (DPP) was a landmark behavior modification intervention 
which was conducted in adults with prediabetes [7]. The DPP and other major clinical trials 
demonstrated the superiority of lifestyle intervention, which promoted weight loss, over 
medication, for preventing T2D [7–9]. Following the success of the DPP, efforts were 
underway to translate the program from academic to clinical and community settings [10]. 
The Bright Bodies study, conducted in youth with prediabetes, demonstrated that behavioral 
modification was effective in reducing glycemia [11]. However, the study was conducted in 
an academic setting, required on-site participation, and presumably, was labor intensive. 
Given the high prevalence of prediabetes in youth [2], who are therefore at risk for 
developing T2D, there is a critical need for a low-cost, home-based prevention program that 
can be individualized and easily integrated into families.
Health coaching is a personalized approach that is being widely used to improve health 
behaviors in patients with chronic conditions including prediabetes [12,13]. In adolescents, 
health coaching is a promising strategy that promotes healthy behaviors using validated 
techniques like motivational interviewing [14,15]. Although data from randomized clinical 
trials in adolescents are limited [16–18], a health coaching behavior modification program 
may be an effective, low-cost, personalized and flexible program that can be implemented 
through clinical or community settings.
A growing body of literature, from longitudinal studies, suggests that diet [19–29], physical 
activity [30,31], and sedentary behavior [32] may modify the risk of development of T2D, 
independent of effects on adiposity. Adolescence is associated with low consumption of 
fruits, vegetables and whole grains, excessive consumption of refined grains, saturated fats 
and added sugars, and high amounts of time spent in sedentary behavior [33–35]. In 
adolescents, we [36] and others [37–39] have shown that high dietary intakes of fat as well 
as sugary foods and beverages are negatively associated with elevated glycemia and insulin 
resistance. Also, high sedentariness negatively influenced insulin secretion and sensitivity in 
youth [40]. It is reasonable therefore that a diabetes prevention program that targets specific 
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diet and activity behaviors which are associated with T2D may be effective for management 
of glycemia.
We have proposed herein an intervention to be conducted in adolescents with prediabetes 
that aims to improve glycemia through modification of specific diet and activity behaviors, 
which reflect guidelines from the American Diabetes Association, American Academy of 
Pediatrics, American Heart Association and U.S. Department of Health and Human Services 
and Department of Agriculture [41–44]. The objective of this trial is to compare the 
effectiveness of a 6-month, home-based, individualized health coaching program, which 
focuses on modification of diet, physical activity, and sedentary behavior, versus a single 
dietary consultation, in preventing T2D in adolescents who are overweight or obese and 
have prediabetes. Health coaches will facilitate behavior change regarding consumption of 
specific foods and time spent in physical activity/inactivity using techniques such as 
motivational interviewing and goal setting that have been shown to increase self-efficacy 
[14,15] (see conceptual framework Fig. 1). We hypothesize that compared to receiving a 
single dietary consult, which is the usual care [45], patients who receive a one-on-one health 
coaching program will exhibit reduced glycemia as measured by 2 h oral glucose tolerance 
test (OGTT) at the end of the 6-month intervention, and that this impact will be sustained for 
an additional 6 months. We expect that increased consumption of specific nutrients and 
foods (dietary fiber, proteins, whole grains and fruits and vegetables), and decreased 
consumption of foods and beverages that are high in saturated fat and in added sugars, will 
modulate improvements which are observed in insulin sensitivity and beta-cell function. The 
research will also explore the contribution of biological, social, and behavioral factors as 
predictors or covariates of gluco-regulation including anthropometric measures of total and 
regional adiposity, measures of sleep behavior, depression, and food insecurity, as well as 
readiness and self-efficacy for behavior change. Perceptions of the health and behavior of 
the adolescent participants, by their parents/guardians, will also be obtained. This 
manuscript describes the study design and methodology for recruitment, data collection and 
data analysis that will test the stated hypothesis.
2. Methods/design
2.1. Recruitment
The main activities of the study are presented in a flow diagram (Fig. 2). Boys and girls who 
are between the ages of 10–21 years and are overweight or obese (body mass index > 85th 
percentile for age and sex) will be recruited into the study. In Indiana, the most recent 
estimates suggest 15.9% of adolescents are overweight and 12.8% are obese, which together 
make up one-third of the adolescent population [46]. Various outreach strategies will be used 
to inform participants/families and health care providers as well as the general community 
about the study. Participants who are recruited through primary care clinics will be 
considered to be recruited by clinic referral. Physicians at pediatric primary care practices in 
the Central Indiana region have been made aware of the study through in-service 
presentations by the study investigators at Indiana University School of Medicine and at 
Purdue University. In addition, we will recruit subjects from Riley Youth Diabetes 
Prevention Clinic (YDPC), Adolescent Medicine Diabetes Clinic, and HealthNet Pediatric 
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and Adolescent Care Center with recruitment assistance by the Indiana Pediatric Research 
Network (PRES-NET, https://www.indianactsi.org/programs/researchnetworks/presnet). 
Participants who are recruited from community-outreach efforts will be considered to be 
recruited via self-referral. Community outreach strategies include sending mass emails and 
flyers to targeted audiences, either through Purdue Extension, or to employees of Purdue 
University. In addition, information about the study can be found at ClinicalTrials. gov, 
registration number NCT02535169.
2.2. Informed consent procedure
Potential participants and their parents/guardians will meet the study team at a public venue 
to obtain informed consent/assent. During this time, participants and families will be 
provided with a detailed description of the study including responsibilities, as well as risks, 
and benefits of participation. Procedures for obtaining consent have been reviewed and 
approved by the Indiana University and Purdue University Institutional Review Boards (IRB 
Study #: 1403986016). After reviewing the materials, and signing the consent forms, 
adolescents will undertake further screening for eligibility to participate in the study. During 
the screening process, participants will undergo a detailed assessment of diet and activity 
behavior to be followed by a clinical assessment of glycemic status and insulin action. Diet 
and activity behavior will be assessed with electronic technology using validated methods 
that are enabled for use in free living individuals.
2.3. Dietary assessment
Dietary information will be collected for four days, including at least one weekend day, 
using the Technology Assisted Dietary Assessment (TADA) mobile food record [47]. The 
TADA application enables individuals to create a mobile food record by capturing food and 
beverage images “before” and “after” eating occasions using the camera on an iPod® [47]. 
The TADA application has been validated in the adolescent population [47,48]. Graduate 
assistants, who are trained in techniques of dietary assessment at the Dietary Assessment 
Center at Purdue, will be involved in the data collection for dietary assessment. Their 
responsibilities will be to 1) review all images with study participants to verify quantities 
and to obtain missing information; and to 2) to create a food record by evaluating each 
before and after image, and determining the food types and portion sizes of each food item, 
using a fiducial marker as a reference. If the fiducial marker is absent, other reference 
markers such as standard plates or utensils will be used. The quantities consumed of foods 
and beverages which are identified from the images will be evaluated using the Nutrition 
Data System for Research (NDSR, developed by the Nutrition Coordinating Center, 
University of Minnesota, Minneapolis, MN). Reported daily intake is calculated as a mean 
of the four days. Levels of intake of nutrients will be compared to those recommended for 
adolescent girls and boys, in the Dietary Guidelines for Americans reports [49,50]. 
Completeness of dietary records will be evaluated by determining energy requirements and 
calculating the percentage of calories reported versus estimated energy requirements. Energy 
requirements were estimated using equations for overweight children and adolescents who 
are in a weight maintenance situation [51]. Underreporting of energy intake will be indicated 
if energy intake is less than 1 standard deviation below predicted energy requirements 
[50,52].
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2.4. Assessment of physical activity and inactivity
Time spent in seated, standing, and ambulatory physical activity will be assessed over 7 days 
using an activPAL™monitor (PAL Technologies, Glasgow, United Kingdom), a device 
which utilizes accelerometer and inclinometer functions [53]. activPAL™ is considered the 
reference method for estimating sedentary time in free-living individuals [54]. The 
inclinometer function is used to detect posture and thus can distinguish between sitting and 
standing. The device is highly objective and more accurate than traditional methods such as 
self-report and survey, and has been validated in the adolescent population [53,55]. The 
instrument also has the capability to measure various tempos of physical activity by 
generating stepping cadence. Data from the activPAL™ will be categorized into six variables 
including four activity intensity levels (light physical activity [LPA], moderate physical 
activity [MPA], vigorous physical activity [VPA] and moderate-to-vigorous physical activity 
[MVPA], plus total steps taken and total stepping time. Children will be classified as 
sedentary if they obtain less than 30 min of MPA; low active if they obtain 30 to 60 min of 
MPA; and active if they obtain greater than 60 min of MPA [51].
2.5. Clinic screening visit
Immediately following the week of collection of dietary and activity information, the study 
volunteer and their parent/guardian will attend a clinical research center (Clinical Research 
Centers at Indiana University Hospital or Riley Hospital for Children) for assessment of 
clinical and anthropometrical measures, which are used to determine their eligibility for the 
study. The participant will attend the screening visit in the morning after an 8-hour overnight 
fast. The clinical and anthropometric measures will include blood pressure, and indices of 
general and abdominal obesity (height, weight, body mass index [BMI], waist circumference 
[WC], hip circumference, and sagittal abdominal diameter [SAD]) [56]. BMI percentiles and 
Z-scores will be calculated from age-and sex-specific reference values as defined by the 
Centers for Disease Control and Prevention (CDC) growth charts [57]. Blood pressure will 
be measured after 5 min of rest, on the right arm in the supine position, using a 
sphygmomanometer with an appropriately sized cuff [58]. An intravenous line will be 
placed and blood is drawn for biochemistries, including concentrations of blood glucose, 
hemoglobin A1c, liver enzymes (alanine amino transferase and aspartate amino transferase), 
as well as a comprehensive lipid profile, and a metabolic panel. Concentrations of plasma 
lipids (total cholesterol, triglycerides [TG], high-density lipoprotein [HDL]), will be 
measured in the Indiana University Core Laboratory, using Alere Cholestech LDX System 
(Alere, Orlando, FL). Low-density lipoprotein (LDL) cholesterol will be calculated using the 
Friedewald equation [59].
Glycemic status (categorized as having normal glucose tolerance [NGT], prediabetes or T2D 
based on American Diabetes Association criteria) [60] will be assessed using an OGTT. 
Blood samples will be obtained at −15, 0, 15, 30, 60, 90, 120 min relative to ingestion of a 
glucose drink in a dose of 1.75 g/kg body weight (maximum 75 g glucose). Concentrations 
of blood glucose and HbA1c will be measured using the i-STAT System (Abbott Point of 
Care, Princeton, NJ) and DCA Vantage Analyzer (Siemens Medical Solutions USA, Inc., 
Malvern, PA) instrumentation respectively, which enable point-of-care testing. For measures 
of insulin action, serum fractions from the OGTT will be frozen at −80 °C until analysis. 
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Concentrations of glucose will be determined using an automated chemistry analyzer 
(COBAS Integra 800, Roche Diagnostics, Indianapolis, IN); insulin, and c-peptide will be 
assessed using an Elecsys Systems immunoassay analyzer (Roche Diagnostics). The 
homeostasis model assessment of insulin resistance (HOMA-IR) will be calculated from 
glucose and insulin concentrations in the fasting state [61]. Whole-body insulin sensitivity 
index (WBISI), the insulinogenic index (IGI), and the oral disposition index (DI) will be 
calculated as described [62,63].
2.6. Eligibility criteria
Participants who meet eligibility criteria, by having a diagnosis of prediabetes, will be 
enrolled into the study intervention and randomly assigned into the single dietary consult 
group or the health coaching intervention. Prediabetes will be defined by having one or more 
of the criteria recommended by the American Diabetes Association, namely: 1) impaired 
fasting plasma glucose (IFG) concentration of 5.6 to 6.9 mmol/L; 2) impaired glucose 
tolerance (IGT) a 2 hour OGTT glucose concentration of 7.8 to 11.0 mmol/L, or 3) an 
elevated hemoglobin A1c concentration of 5.7 to 6.4% [60]. Exclusion criteria include 
pregnancy, use of medications that affect glucose metabolism (such as glucocorticoid-
containing medications or atypical antipsychotics), and syndromic obesity (such as Prader 
Willi, hypothalamic obesity, or Laurence-Moon-Biedl). Participants who are characterized as 
NGT or T2D will not be eligible to enroll in the study and complete the study at this point. 
At the end of the screening clinic visit, all participants, regardless of glycemic status, will 
undergo a consultation with a clinic dietitian regarding diet and lifestyle behaviors.
2.7. Randomization
Randomization will be carried out at subject level, by using the random number generator 
built in the Research Electronic Data Capture software (REDCap, Vanderbilt University, 
Nashville, TN). Specifically, participants will be randomly assigned to the Health Coaching 
or the Single Dietary Consult groups. A randomization table that pre-defines how each 
subject will be randomized as they are added to the study will be generated by a statistician 
and uploaded to the REDCap database. Neither the participants and their families nor the 
study team will be blinded to treatment allocation.
2.8. Description of health coaching intervention and single dietary consult groups
2.8.1. Single dietary consult—For participants who are enrolled in the single dietary 
consult group, a dietary consultation at the end of the screening visit serves as the standard 
of care intervention. The clinic dietitian will provide to the participant and their parental 
guardian, evidence-based, individualized nutrition and physical activity information 
regarding expert guidelines for prevention of obesity and diabetes (U.S. Dietary Guidelines, 
American Heart Association, American Diabetes Association, and American Academy of 
Pediatrics) [41–43,49]. Evidence-based nutrition messages will include: reducing 
consumption of sugary sweetened beverages and foods, increasing fruit and vegetable 
consumption, practicing portion control, reducing the frequency of eating out, and choosing 
healthy snacks. Evidence-based physical activity messages will include: being physically 
active for 60 min daily including cardiovascular, weight bearing, and flexibility exercises, 
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and reducing screen time to 120 min or less per day. Other than the single dietary consult, 
during the intervention, participants in this group will not receive any additional consultation 
from the study dietitian; for further guidance they will be advised about provider services in 
their region.
2.8.2. Health coaching intervention—In addition to receiving a single dietary 
consultation, participants who are randomized to the health coaching intervention will 
receive assistance from a health coach for 6 months to modify diet and activity behavior. 
Health coaches will have undergraduate training from nutrition and kinesiology programs 
and will be highly knowledgeable about clinical practice guidelines regarding diet and 
physical activity strategies for obesity and diabetes management. The protocol for the health 
coaching intervention builds on the DPP framework [64], but will be adapted to be delivered 
via one-on-one counseling with a health coach and tailored to fit each participant’s needs. 
Thus the health coaching program is designed to be a patient-centered approach, focused on 
assisting participants to adopt healthy nutrition and physical activity behaviors, through 
motivational-interviewing and other engagement techniques. Health coaches will also tailor 
the delivery of information and the setting of goals to the participant’s readiness for change 
of specific diet and activity behaviors.
The program consists of weekly phone calls and monthly in person or “face” contacts over 
the course of six months. Participants will meet weekly by phone with the health coach at 
scheduled appointment times. The health coach will offer availability during the evening to 
best accommodate appointment times that are convenient for participants. Communication 
may be delivered by email if preferred.
2.9. Follow-up clinic visits at 6 and 12 months
At 6 months following randomization to the groups, participants will undergo a follow-up 
assessment. As before, during the week prior to a clinic visit, dietary and activity behaviors 
will be assessed under free-living conditions, using the TADA and activPAL™ tools. 
Participants will then return to the clinic for assessment of all other outcomes including 
status of glycemia. To determine the durability of the study intervention, all enrolled 
participants will undergo a similar assessment of diet, activity and glycemic measures at 12 
months following the random assignment to groups. After this assessment, participants will 
have completed the study. At this time, focus groups will be conducted with participants and 
their parents/guardians to obtain feedback about their experience, and the discussions will 
also include quantitative and qualitative measures of patient satisfaction [65].
2.10. Outcomes
Outcomes will to be obtained at baseline and at 6 and 12 months following random 
assignment into the health coaching or dietary consult groups. A listing of all study 
outcomes and the timing of collection is provided in Table 1.
2.11. Data analysis and sample size estimates
Data will be analyzed using linear mixed-effect models and controlled for a subject level 
effect. Adjusted means will be reported for the different treatments at the different time 
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points (baseline, 6 month post intervention, and 12 month follow up). Confounding factors 
such as sex. Race/ethnicity and age, as well as dietary intakes of nutrients and physical 
activity known to influence glycaemia and insulin action dynamics, will be controlled for in 
the linear mixed models. Since other outcomes including sleep [66] and mood disturbances 
[67] may affect study outcomes, we may include these in the model. Continuous data will be 
tested for normality and if the data is skewed, log transformation may be used to normalize 
data or non-parametric statistics will be used. Differences between groups will be analyzed 
using Chi-squared for categorical data and independent t-tests for continuous data. Data will 
be expressed as mean ± standard error, and P values less than or equal to 0.05 will be 
considered to indicate significant differences.
A sample size of 35 per group will be needed to determine an effect size of 0.67 standard 
deviations as statistically significant at a two sided an alpha level of 0.05 and power of 0.8. 
This sample size will detect a difference of 0.17 mg/dL 0.94 mM in concentration of glucose 
at 2 h following the OGTT as statistically significant assuming a standard deviation of 
approximately 25 mg/dL (1.4 mM) [11]. To account for an attrition of 30%, this sample size 
will be increased to 46 per group.
3. Discussion
The DIG IT intervention aims to determine if health coaching can be used to prevent type 2 
diabetes by improving self-efficacy of adolescents (and their families) regarding 
incorporation of healthy diet and activity behaviors. The prevalence of prediabetes in 
adolescents is high [2], fueled by the rising rates of obesity in this population [68]. In the 
context of the emerging epidemic of youth-onset T2D, an emphasis on strategies for 
prevention is warranted, especially since effective strategies for treatment are lacking. 
Lifestyle behaviors of adolescents are characteristically low in amount of physical activity, 
and excessively sedentary, high in dietary intake of refined grains, saturated fats and added 
sugars, and low in intake of fruits and vegetables. Independent of obesity, these lifestyle 
factors may promote the risk of developing T2D [36–40]. An intensive behavior 
modification program, demonstrated the efficacy of lifestyle intervention to improve 
nutrition and physical activity for reducing the risk of type 2 diabetes in adolescents, but it 
was conducted in the academic setting [11]. Such studies demonstrate efficacy but may be 
limited in ability to reach broad populations. Therefore there is a critical need for 
randomized controlled trials to translate diabetes prevention programs to the community or 
clinical setting.
Health coaches use a personalized approach that involves goal setting and motivational 
interviewing to assist individuals with behavior change. This approach may be successful in 
promoting the self-efficacy of adolescents, and their families, to adopt a healthy lifestyle. 
Potential advantages of using health coaches are 1) they are highly knowledgeable about 
evidence-based practices for lifestyle modification; 2) they can tailor recommendations to 
meet individual challenges and barriers; and 3) interactions between health coaches and 
participants can be convenient and inexpensive since they will be conducted through phone 
calls and email. The DIG IT protocol described will determine whether health coaching can 
be used to promote behavior change in adolescents in the free-living environment.
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The impact of health coaching on diet and physical activity behaviors of the participants will 
be evaluated using objective measures that are non-invasive and well suited to the free-living 
environment. The TADA and activPAL instruments have been validated in adolescents to 
obtain highly-detailed information on diet and activity/inactivity. The measures will be used 
to assess participant’s adherence to the messages received from the intervention in terms of 
health coaching or single dietary consult. Thus we will be able to evaluate the fidelity of the 
treatment by directly assessing target behaviors. In addition, diabetes risk will be assessed 
using oral glucose tolerance testing which yields dynamic measures of insulin resistance and 
beta-cell function. We believe that the detail of information on diet, physical activity/
inactivity as well as glucose and insulin action is a novel aspect of this project. Limitations 
of the protocol are that the neither the participants nor the study team will be blinded to 
treatment allocation, thus findings will be subjected to expectation bias. The data obtained 
may inform about direct influence of specific diet, activity as well as sedentary factors on 
markers of diabetes risk. This information will provide useful information about specific 
modifiable targets, besides weight loss, for preventing diabetes in adolescents who are at 
risk. Weight loss is particularly challenging to achieve in adolescents [6], therefore a low-
cost, health coaching approach which enables adolescents to incorporate lifestyle behaviors 
that are anti-diabetogenic may have a positive and widespread impact on this emerging 
major public health issue.
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Fig. 1. 
Conceptual framework of study.
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Table 1
Description of outcome measures.
Measures Detail of measures obtained Instrument
To be collected at screening/baseline, end of intervention (6 month) and follow-up (12 month)
Primary outcomes
Glycemia Glucose at 2 h OGTT COBAS Integra 800
Secondary outcomes
Glycemia Fasting glucose, HbA1c Elecsys Systems
Insulin action WBISI, IGI, DI
HOMA
Elecsys Systems
Dietary intake Nutrients (saturated fat, fiber); foods and food 
groups
TADA
Activity behavior LPA, MPA, VPA, MVPA, total steps, total stepping 
time
activPAL™
Sedentary behavior Time spent sitting/lying activPAL™
Anthropometry Height, weight, BMI, waist and hip circumference, 
SAD
Per NHANES protocols [56]
Metabolic risk profile Plasma lipids (TC, TG, HDL, LDL), blood pressure 
(SBP, DBP)
Indiana University Core Laboratory and [58]
Sleep quality Sleep duration, sleep debt, sleep disorders Cleveland Adolescent Sleepiness Questionnaire 
[69]; Sleep Disturbances Scale [70]
Quality of life Functioning (physical, emotional, social and school) PedsQL – Child Self Report [71]
Depression 9-Items of depressive signs and symptoms Patient Health Questionnaire [72]
Disordered eating Screening for anorexia or bulimia nervosa SCOFF Questionnaire [73]
Stage of change for health 
behavior
Use of behavior strategies, self-efficacy Behavioral Strategies Questionnaire [74] [75]
Perception of food insecurity Food security status Child Food Security Survey Module [76]
Measures obtained from parent/guardian
Parental perceptions of behavior Perceived problems with weight-related behavior 
and self-efficacy
The parental perceptions of participant’s 
behavior: the lifestyle behavior checklist [77]
Stage of change for health 
behavior
Parent perception of use of behavioral strategies Behavioral Strategies Questionnaire – for parents 
[74] [75]
Quality of life Parent’s perception of child’s functioning (physical, 
emotional, social, and school)
PedsQL parent proxy-report [78]
Food security Prevalence of food insecurity U.S. Household Food Security Survey Module 
[76]
To be collected at 12 month follow-up
Focus groups Participant/guardian satisfaction with the study Quantitative and qualitative questions about 
satisfaction with study [65]
Abbreviations: HbA1c, hemoglobin A1c; OGTT, oral glucose tolerance test; WBISI, whole body insulin sensitivity index; IGT, insulinogenic 
index; DI, disposition index; HOMA, homeostatic model assessment; TADA, Technology Assisted Dietary Assessment; LPA, light physical 
activity; MPA, moderate physical activity; VPA, vigorous physical activity; MVPA, moderate to vigorous physical activity; NHANES, National 
Health and Nutrition Examination Survey; TC, total cholesterol; TG, triglycerides; HDL, high density lipoprotein; LDL, low density lipoprotein; 
SBP, systolic blood pressure; DBP, diastolic blood pressure.
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